{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:06:45Z","timestamp":1753891605186,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Hereditary transthyretin amyloidosis (ATTRv amyloidosis) is a rare neurological hereditary disease clinically characterized as severe, progressive, and life-threatening while the age of onset represents the moment in time when the first symptoms are felt. In this study, we present and discuss our results on the study, development, and evaluation of an approach that allows for time-to-event prediction of the age of onset, while focusing on genealogical feature construction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>This research was triggered by the need to answer the medical problem of when will an asymptomatic ATTRv patient show symptoms of the disease. To do so, we defined and studied the impact of 77 features (ranging from demographic and genealogical to familial disease history) we studied and compared a pool of prediction algorithms, namely, linear regression (LR), elastic net (EN), lasso (LA), ridge (RI), support vector machines (SV), decision tree (DT), random forest (RF), and XGboost (XG), both in a classification as well as a regression setting; we assembled a baseline (BL) which corresponds to the current medical knowledge of the disease; we studied the problem of predicting the age of onset of ATTRv patients; we assessed the viability of predicting age of onset on short term horizons, with a classification framing, on localized sets of patients (currently symptomatic and asymptomatic carriers, with and without genealogical information); and we compared the results with an out-of-bag evaluation set and assembled in a different time-frame than the original data in order to account for data leakage.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Currently, we observe that our approach outperforms the BL model, which follows a set of clinical heuristics and represents current medical practice. Overall, our results show the supremacy of SV and XG for both the prediction tasks although impacted by data characteristics, namely, the existence of missing values, complex data, and small-sized available inputs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>With this study, we defined a predictive model approach capable to be well-understood by medical professionals, compared with the current practice, namely, the baseline approach (BL), and successfully showed the improvement achieved to the current medical knowledge.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1216214","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T02:55:02Z","timestamp":1689648902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical model for Hereditary Transthyretin Amyloidosis age of onset prediction"],"prefix":"10.3389","volume":"14","author":[{"given":"Maria","family":"Pedroto","sequence":"first","affiliation":[]},{"given":"Teresa","family":"Coelho","sequence":"additional","affiliation":[]},{"given":"Al\u00edpio","family":"Jorge","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Mendes-Moreira","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"27","author":"Benson","year":"2020","journal-title":"Amyloid"},{"key":"B2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Ando","year":"2013","journal-title":"Orph J Rare Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"ehs123","DOI":"10.1093\/eurheartj\/ehs123","article-title":"Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/13506129.2020.1857236","article-title":"Beyond Val30Met transthyretin (TTR): variants associated with age-at-onset in hereditary ATTRv amyloidosis","volume":"28","author":"Alves-Ferreira","year":"2021","journal-title":"Amyloid"},{"key":"B5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jns.2009.05.018","article-title":"Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met","volume":"284","author":"Dardiotis","year":"2009","journal-title":"J Neurol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-16399-0","author":"Steyerberg","year":"2019","journal-title":"Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating, 2nd Edn."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s11906-020-01071-z","article-title":"Age of hypertension onset: overview of research and how to apply in practice","volume":"9","author":"Suvila","year":"2020","journal-title":"Tech Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1474-4422(19)30394-1","article-title":"Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study","volume":"19","author":"Moore","year":"2020","journal-title":"Lancet Neurol"},{"year":"1995","author":"Sousa","journal-title":"A variabilidade fenot\u00edpica da Polineuropatia Amiloid\u00f3tica Familiar: um estudo de gen\u00e9tica quantitativa em Portugal e na Su\u00e9cia (Phenotypic Variability of Familial Amyloid Polyneuropathy: A Quantitative Genetics Study in Portugal and in Sweden)","key":"B9"},{"key":"B10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/13506129.2017.1293515","article-title":"Refine penetrance estimates in the main pathogenic variants of transthyretin hereditary (familial) amyloid polyneuropathy (TTR-FAP) using a new non-parametric approach (NPSE)","volume":"24","author":"Gorram","year":"2017","journal-title":"Amyloid"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-019-1000-1","article-title":"Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series","volume":"14","author":"Waddington-Cruz","year":"2019","journal-title":"Orph J Rare Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/13506129.2015.1051219","article-title":"Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14\u2013333 African\u2013Americans","volume":"22","author":"Jacobson","year":"2015","journal-title":"Amyloid"},{"key":"B13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/jnnp.59.1.45","article-title":"Familial amyloid polyneuropathy (TTR ala 60) in north west Ireland: a clinical, genetic, and epidemiological study","volume":"59","author":"Reilly","year":"1995","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/archneur.59.11.1771","article-title":"Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs. late-onset form","volume":"11","author":"Koike","year":"2002","journal-title":"Archiv Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"305383","DOI":"10.1136\/jnnp-2013-305383","article-title":"Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M","volume":"2013","author":"Lemos","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/WCO.0000000000000290","article-title":"Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis","volume":"29","author":"Obici","year":"2016","journal-title":"Curr Opin Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/13506129.2022.2052838","article-title":"Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis","volume":"29","author":"Ando","year":"2022","journal-title":"Amyloid"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/13506129.2018.1556156","article-title":"Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations","volume":"26","author":"Concei\u00e7\u00e3o","year":"2019","journal-title":"Amyloid"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13506129.2023.2178891","article-title":"A multicentric study of the disease risks and first manifestations in Hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis","volume":"2023","author":"Plant\u00e9-Bordeneuve","year":"2023","journal-title":"Amyloid"},{"key":"B20","first-page":"199","article-title":"Predicting age of onset in TTR-FAP patients with genealogical features","author":"Pedroto","year":"2018"},{"key":"B21","first-page":"35","article-title":"Impact of genealogical features in transthyretin familial amyloid polyneuropathy age of onset prediction","author":"Pedroto","year":"2019"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-16474-3_16","article-title":"Improving the prediction of age of onset of TTR-FAP patients using graph-embedding features","author":"Petroto","year":"2022","journal-title":"Progress in Artificial Intelligence. EPIA 2022. Lecture Notes in Computer Science, Vol. 13566."},{"key":"B23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jalgor.2005.08.001","article-title":"Lowest common ancestors in trees and directed acyclic graphs 1","volume":"57","author":"Bender","year":"2005","journal-title":"J Algorithms"},{"key":"B24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/21678421.2021.1924207","article-title":"Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic","volume":"22","author":"Beaulieu","year":"2021","journal-title":"Amyotr Lat Scler Frontotemp Degener"},{"year":"2010","author":"Petersohn","journal-title":"Temporal Video Segmentation.","key":"B25"},{"key":"B26","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00439-011-1022-9","article-title":"Anticipation in hereditary disease: the history of a biomedical concept","volume":"130","author":"Friedman","year":"2011","journal-title":"Hum Genet"},{"key":"B27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jmg.30.5.388","article-title":"Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis","volume":"30","author":"Drugge","year":"1993","journal-title":"J Med Genet"},{"key":"B28","first-page":"748","article-title":"Change in the age of onset in patients with familial amyloidotic polyneuropathy type I","volume":"34","author":"Tashima","year":"1995","journal-title":"Japan Soc Intern Medicine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/13506129.2020.1789580","article-title":"Anticipation on age at onset in kindreds with hereditary ATTRV30M amyloidosis from the Majorcan cluster","volume":"2020","author":"Cisneros-Barroso","year":"2020","journal-title":"Amyloid"},{"key":"B30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/WCO.0000000000000288","article-title":"Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe","volume":"2016","author":"Parman","year":"2016","journal-title":"Curr Opin Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1216214\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T02:55:06Z","timestamp":1689648906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1216214\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":30,"alternative-id":["10.3389\/fneur.2023.1216214"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1216214","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2023,7,17]]},"article-number":"1216214"}}